59148-400Level 3
VOYXACT (sibeprenlimab)
**Product type:** Human Prescription Drug
**Active ingredient:** SIBEPRENLIMAB
**Strength:** 200 mg/mL
**Dosage form:** Injection
**Route:** Subcutaneous
**Labeler:** Otsuka America Pharmaceutical, Inc.
**Marketing category:** BLA (BLA761434)
GET
/api/v1/systems/ndc_fda/nodes/59148-400Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.